Cambridge Angels is a group of more than 60 high net worth investors who have experience as successful entrepreneurs in technology, internet, software, hardware, and healthcare sectors. Members invest in and mentor early stage companies across the UK.
The Cambridge-based engineering firm secured backing from ACF Investors, Cambridge Angels, and Tony Purnell to ramp up manufacturing of its M2 model.
"As cycling enthusiasts, we wanted to help people find better ways to move around cities. Unlike traditional e-bikes that retrofit motors and batteries onto non-electric designs, we build from the ground up, integrating folding and electric capabilities from the start. By applying aerospace-grade bonding techniques, we’ve eliminated the distortions caused by welding, resulting in a lighter, stronger, and more compact design. Our mission has always been to make cycling easier and more accessible for urban commuters, and this funding allows us to take that mission to the next level with the FLIT M2."
The funding round was backed by the South West Investment Fund, Oxford Innovation Finance and Cambridge Angels.
"The biodiversity collapse is one of the top global risks identified by the World Economic Forum, with over half of the world’s GDP relying on nature. Our technology addresses the urgent need for accurate, scalable, and unbiased biodiversity monitoring around the world. This investment will enable us to enhance our platform and expand our reach, helping industries and government bodies make informed decisions backed by solid data."
The pre-seed round was led by Tony Mallin MBE of Star Capital alongside Cambridge Enterprise and Cambridge Angels.
"WYA links people with their peers and strengthens the ability to keep contact with those that you’re out with, even when they’ve wandered away and phone signal is limited. Tamzin and the team have been a dream to work with, with a modern eye for developing customer and venue safety through their stunning app"
— James Slater, Venue Operations Manager at The Level (NTSU)
Hargreave Hale AIM VCT led the financing round to help accelerate the company platform and expand into new disease areas.
"The close of our Series A round marks the 'end of the beginning' and the start of a new chapter for Qureight, as we turn our focus to developing our platform and creating products in new disease areas. Our mission to extend the lives of lung and heart disease patients will be bolstered by the invaluable expertise of our new board and new senior team members, and we are looking forward to adding to our strategic biopharma collaborations."
The funding round was led by The Yield Lab, STIHL Ventures, and ACF Investors to drive global product growth.
"The Spotta platform built by Robert, Neil and the team delivers a real solution which can completely turn the insect pest control industry on its head. With their smart 24/7 monitoring enabling customers to precision target treatment for the first time. It’s a solution that protects people and crops but also hugely reduces the cost and environmental impact of treatment."
